BioProspect Limited (ASX:BPO) has been granted a trading halt by the ASX, with its shares placed in pre-open.
BioProspect requested the halt pending a corporate restructure.
In July this year Stephen Pearce, which chief financial officer for Fortescue Metals Group (ASX:FMG), was appointed an advisor to the company.
The halt will remain in place until the opening of trade on Monday 8th September 2014, or earlier if an announcement is made to the market.
